(RxWiki News) The first generic version of Crestor (rosuvastatin) has received approval from the US Food and Drug Administration (FDA).
Crestor belongs to a group of drugs called HMG-CoA reductase inhibitors, also known as statins. Crestor works by blocking the production of cholesterol in the body.
Rosuvastatin has been approved to treat the following:
- High triglycerides in adults (in combination with diet)
- A disorder associated with improper breakdown of cholesterol and triglycerides known as primary dysbetalipoproteinemia (in combination with diet)
- A disorder associated with high low-density lipoprotein (LDL) cholesterol known as homozygous familial hypercholesterolemia in adults
High LDL cholesterol, also known as bad cholesterol, and high triglycerides are risk factors for heart disease.
The generic version of Crestor was approved because it met standards established by the FDA in regards to identity, strength, quality, purity and potency.
Rosuvastatin will be marketed by Watson Pharmaceuticals, Inc.
Speak to your pharmacist about any questions you may have about Crestor and its generic.